Testing the blood of cancer patients for presence of metabolites can determine if a drug is effective or not. The method was first developed for pictilisib but researchers say it can also be used for other cancer therapies.
Testing the blood of cancer patients for presence of metabolites can determine if a drug is effective or not. The method was first developed for pictilisib but researchers say it can also be used for other cancer therapies.